KR101253106B1 - Method for preparing intermediate of sitagliptin using chiral oxirane - Google Patents

Method for preparing intermediate of sitagliptin using chiral oxirane Download PDF

Info

Publication number
KR101253106B1
KR101253106B1 KR1020090093894A KR20090093894A KR101253106B1 KR 101253106 B1 KR101253106 B1 KR 101253106B1 KR 1020090093894 A KR1020090093894 A KR 1020090093894A KR 20090093894 A KR20090093894 A KR 20090093894A KR 101253106 B1 KR101253106 B1 KR 101253106B1
Authority
KR
South Korea
Prior art keywords
trifluorophenyl
oxysilane
trifluorobenzyl
preparing
trifluorobenzene
Prior art date
Application number
KR1020090093894A
Other languages
Korean (ko)
Other versions
KR20110036308A (en
Inventor
김남두
장지연
정재혁
이현승
김동준
장영길
이관순
Original Assignee
한미사이언스 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 한미사이언스 주식회사 filed Critical 한미사이언스 주식회사
Priority to KR1020090093894A priority Critical patent/KR101253106B1/en
Priority to PCT/KR2010/006346 priority patent/WO2011040717A2/en
Priority to ARP100103536A priority patent/AR079102A1/en
Priority to TW099133271A priority patent/TW201118101A/en
Publication of KR20110036308A publication Critical patent/KR20110036308A/en
Application granted granted Critical
Publication of KR101253106B1 publication Critical patent/KR101253106B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/01Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/36Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/08Preparation of carboxylic acids or their salts, halides or anhydrides from nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/42Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/56Unsaturated compounds containing hydroxy or O-metal groups containing halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/08Compounds containing oxirane rings with hydrocarbon radicals, substituted by halogen atoms, nitro radicals or nitroso radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Epoxy Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

본 발명은 시타글립틴 제조시의 주요 중간체인 3-히드록시-4-(2,4,5-트리플루오로페닐)-부티르산, 특히, (3S)-3-히드록시-4-(2,4,5-트리플루오로페닐)-부티르산의 제조방법에 관한 것으로, 본 발명의 제조방법에 의해 용이하고 경제적으로 시타글립틴의 중간체를 제조할 수 있다.The present invention relates to 3-hydroxy-4- (2,4,5-trifluorophenyl) -butyric acid, in particular (3S) -3-hydroxy-4- (2, The present invention relates to a method for producing 4,5-trifluorophenyl) -butyric acid, and an intermediate of cytagliptin can be prepared easily and economically by the production method of the present invention.

시타글립틴, 중간체, 제조방법, 키랄 옥실레인 Citagliptin, Intermediates, Manufacturing Method

Description

키랄 옥실레인을 이용한 시타글립틴 중간체의 제조방법 {METHOD FOR PREPARING INTERMEDIATE OF SITAGLIPTIN USING CHIRAL OXIRANE}Method for preparing cytagliptin intermediate using chiral oxysilane {METHOD FOR PREPARING INTERMEDIATE OF SITAGLIPTIN USING CHIRAL OXIRANE}

본 발명은 시타글립틴 제조시의 주요 중간체인 3-히드록시-4-(2,4,5-트리플루오로페닐)-부티르산, 특히, (3S)-3-히드록시-4-(2,4,5-트리플루오로페닐)-부티르산의 제조방법에 관한 것이다.The present invention relates to 3-hydroxy-4- (2,4,5-trifluorophenyl) -butyric acid, in particular (3S) -3-hydroxy-4- (2, A method for producing 4,5-trifluorophenyl) -butyric acid.

시타글립틴 포스페이트는 제2세대 DPP-4(dipeptidyl peptidase IV)를 선택적으로 억제하여 인크레틴 (incretin) 농도를 유지하게 하는 약물로, 모노하이드레이트 형태로 2006년 10월에 제2형 단백질 환자의 식이 및 운동요법 보조제로서 FDA에 의해 승인되었으며, 현재 한국 또는 미국에서는 단일 제제로서 자뉴비아(JanuviaTM), 메트폴민과의 경구용 복합제제로서 자누메트(JanumetTM)로서 판매되고 있다.Cytagliptin phosphate selectively inhibits the second generation of dipeptidyl peptidase IV (DPP-4) to maintain incretin concentrations. In the monohydrate form, it was approved by the FDA in October 2006 as a dietary and exercise therapy adjunct to patients with type 2 protein, and currently in Korea or the United States as a single agent oral with Januvia TM or metpolmin. It is marketed as Janumet as a composite formulation for the present invention.

이러한 시타글립틴 포스페이트는 다양한 방법으로 제조되고 있는데, 일례로, 국제특허공개 제 WO2004/085661호에는, 백금촉매(PtO2)를 이용하여 엔아민(enamine)을 입체선택적으로 환원하는 과정을 거쳐 시타글립틴을 제조하는 방법이 개시되어 있다.Such citagliptin phosphate is manufactured by various methods. For example, International Patent Publication No. WO2004 / 085661 discloses a theta after stereoselectively reducing enamine using a platinum catalyst (PtO 2 ). A method of making gliptin is disclosed.

다른 예로, 국제특허공개 제 WO2005/097733호에는 로듐촉매([Rh(cod)Cl]2)와 키랄 다이포스핀리간드를 이용하여 엔아민을 입체선택적으로 환원하는 과정을 거쳐 시타글립틴을 제조하는 방법이 개시되어 있다. As another example, International Patent Publication No. WO2005 / 097733 discloses the preparation of cytagliptin through a process of stereoselectively reducing enamine using a rhodium catalyst ([Rh (cod) Cl] 2 ) and a chiral diphosphine ligand. A method is disclosed.

또 다른 예로, 문헌(J. Am . Chem . Soc., 2009, 131, p.11316-11317)에는 루테늄 촉매(Ru(OAc)2)와 키랄 다이포스핀리간드를 이용하여 엔아민을 입체선택적으로 환원하는 과정을 거쳐 시타글립틴을 제조하는 방법이 개시되어 있고, 국제특허공개 제 WO2009/064476호에는 루테늄 촉매(Ru(OAc)2)와 키랄 다이포스핀리간드 또는 키랄 산과 보로하이드라이드(예를 들어, NaBH4)를 이용하여 엔아민을 입체선택적으로 환원하는 과정을 거쳐 시타글립틴을 제조하는 방법이 개시되어 있다.As another example, J. Am . Chem . Soc ., 2009, 131 , p.11316-11317 includes a ruthenium catalyst (Ru (OAc) 2 ) and a chiral diphosphine ligand to stereoselectively select enamines. A method for producing cytagliptin through reduction is disclosed, and WO 2009/064476 discloses a ruthenium catalyst (Ru (OAc) 2 ), a chiral diphosphine ligand, or a chiral acid and borohydride (e.g., For example, a method of preparing cytagliptin through a process of stereoselectively reducing enamine using NaBH 4 ) is disclosed.

이외 3-히드록시-4-(2,4,5-트리플루오로페닐)-부티르산, 특히 (3S)-3-히드록시-4-(2,4,5-트리플루오로페닐)-부티르산을 중간체로 사용하여 시타글립틴 포스페이트를 제조하는 방법이 있다.Other 3-hydroxy-4- (2,4,5-trifluorophenyl) -butyric acid, in particular (3S) -3-hydroxy-4- (2,4,5-trifluorophenyl) -butyric acid There is a method for preparing cytagliptin phosphate using as an intermediate.

일례로, 국제특허공개 제 WO2004/087650호에는 하기 반응식 1에서와 같이 (3S)-3-히드록시-4-(2,4,5-트리플루오로페닐)-부티르산으로부터 5 단계를 거쳐 시타글립틴 포스페이트를 제조하는 방법이 개시되어 있다. As an example, WO 2004/087650 discloses cytagles through five steps from (3S) -3-hydroxy-4- (2,4,5-trifluorophenyl) -butyric acid as shown in Scheme 1 below. A method of preparing liptin phosphate is disclosed.

Figure 112009060635890-pat00001
Figure 112009060635890-pat00001

상기 식에서 Bn은 벤질을 나타낸다. Wherein Bn represents benzyl.

또한 상기 국제특허공개 제 WO2004/087650호에는 하기 반응식 2에서와 같이 메틸 4-(2,4,5-트리플루오로페닐)-3-옥소부티레이트를 (S)-BINAP-RuCl2 ·Et3N 촉매 존재 하에 고압의 수소를 이용하여 입체선택적으로 환원한 후, 가수분해하여 시타글립틴의 주요 중간체인 (3S)-3-히드록시-4-(2,4,5-트리플루오로페닐)-부티르산을 제조하는 방법이 개시되어 있다. Further, the International Patent Publication No. WO2004 / 087650 discloses to methyl 4 as shown in scheme 2 (2,4,5-trifluorophenyl) -3-oxo-butyrate to (S) -BINAP-RuCl 2 · Et 3 N Stereoselective reduction with hydrogen at high pressure in the presence of a catalyst, followed by hydrolysis to yield (3S) -3-hydroxy-4- (2,4,5-trifluorophenyl)-the main intermediate of cytagliptin. A method of making butyric acid is disclosed.

Figure 112009060635890-pat00002
Figure 112009060635890-pat00002

시타글립틴의 중간체 제조와 관련된 다른 예로, 국제특허공개 제 WO2009/045507호에는 하기 반응식 3 및 4에서와 같이 메틸 4-(2,4,5-트리플루오로페닐)-3-옥소부티레이트를 엔자임을 이용하여 입체선택적으로 환원시킴으로써 시타글립틴의 주요 중간체인 메틸 (3S)-3-히드록시-4-(2,4,5-트리플루오로페닐)-부티레이트 또는 메틸 (3R)-3-히드록시-4-(2,4,5-트리플루오로페닐)-부티레이트를 제조하는 방법이 개시되어 있다.In another example relating to the preparation of intermediates for cytagliptin, WO 2009/045507 discloses methyl 4- (2,4,5-trifluorophenyl) -3-oxobutyrate as enzymes, as shown in Schemes 3 and 4. By stereoselective reduction using methyl (3S) -3-hydroxy-4- (2,4,5-trifluorophenyl) -butyrate or methyl (3R) -3-hydride as the major intermediate of cytagliptin A process for preparing oxy-4- (2,4,5-trifluorophenyl) -butyrate is disclosed.

Figure 112009060635890-pat00003
Figure 112009060635890-pat00003

Figure 112009060635890-pat00004
Figure 112009060635890-pat00004

그러나, 상기 방법들은 시타글립틴의 주요 중간체인 (3S)-3-히드록시-4-(2,4,5-트리플루오로페닐)-부티르산의 제조시, 루테늄 촉매 존재 하의 고압의 수소를 이용하거나, 케톤 환원효소를 이용하여 (3S)-3-히드록시-4-(2,4,5-트리플루오로페닐)-부티르산의 3번 위치에 키랄중심을 도입하였다.However, these methods utilize high pressure hydrogen in the presence of a ruthenium catalyst in the preparation of (3S) -3-hydroxy-4- (2,4,5-trifluorophenyl) -butyric acid, the main intermediate of cytagliptin. Alternatively, a chiral center was introduced at position 3 of (3S) -3-hydroxy-4- (2,4,5-trifluorophenyl) -butyric acid using ketone reductase.

이에 본 발명자들은 시타글립틴의 제조 및 그 중간체의 용이한 제조에 대해 예의 연구를 지속한 결과, 상업적으로 용이하게 입수 가능한 (S)-에피클로로히드린으로부터 제조된 키랄 옥실레인인 (2S)-2-(2,4,5-트리플루오로벤질)-옥실레인을 이용함으로써 (3S)-3-히드록시-4-(2,4,5-트리플루오로페닐)-부티르산을 저렴하고 용이하게 제조할 수 있음을 발견하고, 본 발명을 완성하게 되었다.Accordingly, the inventors have intensively studied the preparation of cytagliptin and the easy preparation of the intermediate thereof, and as a result, commercially available chiral oxysilane (2S)-made from (S) -epichlorohydrin is commercially available. (3S) -3-hydroxy-4- (2,4,5-trifluorophenyl) -butyric acid inexpensively and easily by using 2- (2,4,5-trifluorobenzyl) -oxysilane It has been found that the present invention can be made and the present invention has been completed.

따라서, 본 발명의 목적은 시타글립틴 제조시의 주요 중간체인 3-히드록시-4-(2,4,5-트리플루오로페닐)-부티르산, 특히, (3S)-3-히드록시-4-(2,4,5-트리플루오로페닐)-부티르산의 제조방법을 제공하는 것이다.Accordingly, an object of the present invention is to provide 3-hydroxy-4- (2,4,5-trifluorophenyl) -butyric acid, in particular (3S) -3-hydroxy-4, which is a major intermediate in the preparation of cytagliptin. It is to provide a method for producing-(2,4,5-trifluorophenyl) -butyric acid.

본 발명의 다른 목적은 상기 3-히드록시-4-(2,4,5-트리플루오로페닐)-부티르산의 제조에 이용되는 (2S)-2-(2,4,5-트리플루오로벤질)-옥실레인 및 4-(2,4,5-트리플루오로페닐)-3-히드록시부탄니트릴을 제공하는 것이다.Another object of the present invention is (2S) -2- (2,4,5-trifluorobenzyl, which is used to prepare 3-hydroxy-4- (2,4,5-trifluorophenyl) -butyric acid. ) -Oxysilane and 4- (2,4,5-trifluorophenyl) -3-hydroxybutanenitrile.

상기 목적을 달성하기 위하여, 본 발명은 In order to achieve the above object,

하기 화학식 2a의 2-(2,4,5-트리플루오로벤질)-옥실레인을 촉매 존재 하에서 니트릴화 반응시켜 하기 화학식 3a의 4-(2,4,5-트리플루오로페닐)-3-히드록시부탄니트릴을 제조하는 단계; 및2- (2,4,5-trifluorobenzyl) -oxysilane of formula (2a) was subjected to nitrilation in the presence of a catalyst to 4- (2,4,5-trifluorophenyl) -3- Preparing hydroxybutanenitrile; And

상기 제조된 4-(2,4,5-트리플루오로페닐)-3-히드록시부탄니트릴을 강염기 존재 하에 가수분해시키는 단계를 포함하는, 하기 화학식 1a의 3-히드록시-4-(2,4,5-트리플루오로페닐)-부티르산의 제조방법을 제공한다: Hydrolysis of the prepared 4- (2,4,5-trifluorophenyl) -3-hydroxybutannitrile in the presence of a strong base, 3-hydroxy-4- (2, Provided are methods for preparing 4,5-trifluorophenyl) -butyric acid:

Figure 112009060635890-pat00005
Figure 112009060635890-pat00005

Figure 112009060635890-pat00006
Figure 112009060635890-pat00006

Figure 112009060635890-pat00007
Figure 112009060635890-pat00007

바람직하게는 상기 2-(2,4,5-트리플루오로벤질)-옥실레인은 하기 화학식 2b의 (2S)-2-(2,4,5-트리플루오로벤질)-옥실레인이다:Preferably the 2- (2,4,5-trifluorobenzyl) -oxysilane is (2S) -2- (2,4,5-trifluorobenzyl) -oxysilane of formula 2b:

Figure 112009060635890-pat00008
Figure 112009060635890-pat00008

또한, 본 발명은 상기 3-히드록시-4-(2,4,5-트리플루오로페닐)-부티르산의 제조에 이용되는 상기 화학식 2b의 (2S)-2-(2,4,5-트리플루오로벤질)-옥실레인 및 상기 화학식 3a의 4-(2,4,5-트리플루오로페닐)-3-히드록시부탄니트릴을 제공한다.In addition, the present invention provides (2S) -2- (2,4,5-tri of Formula 2b used in the preparation of 3-hydroxy-4- (2,4,5-trifluorophenyl) -butyric acid. Fluorobenzyl) -oxysilane and 4- (2,4,5-trifluorophenyl) -3-hydroxybutannitrile of Formula 3a are provided.

본 발명의 제조방법에 따르면, 용이하고 경제적으로 시타글립틴의 주요 중간체인 3-히드록시-4-(2,4,5-트리플루오로페닐)-부티르산, 특히 (3S)-3-히드록시-4-(2,4,5-트리플루오로페닐)-부티르산을 효율 좋게 제조할 수 있기 때문에, 공업적으로 응용이 용이하다.According to the preparation method of the present invention, 3-hydroxy-4- (2,4,5-trifluorophenyl) -butyric acid, in particular (3S) -3-hydroxy, which is a major intermediate of cytagliptin easily and economically Since 4- (2,4,5-trifluorophenyl) -butyric acid can be produced efficiently, industrial application is easy.

이하, 본 발명을 보다 상세히 설명한다.Hereinafter, the present invention will be described in more detail.

본 발명은 시타글립틴의 주요 중간체인 3-히드록시-4-(2,4,5-트리플루오로페닐)-부티르산, 특히 (3S)-3-히드록시-4-(2,4,5-트리플루오로페닐)-부티르산을 키랄 옥실레인을 이용하여 저비용으로 용이하고 효율적으로 제조하는 것을 특징으로 한다.The present invention relates to 3-hydroxy-4- (2,4,5-trifluorophenyl) -butyric acid, in particular (3S) -3-hydroxy-4- (2,4,5), which is a major intermediate of cytagliptin. -Trifluorophenyl) -butyric acid is produced easily and efficiently at low cost using chiral oxysilane.

즉, 본 발명에 따른 제조방법은, 상기 화학식 2a의 2-(2,4,5-트리플루오로벤질)-옥실레인을 촉매 존재 하에서 니트릴화 반응시켜 상기 화학식 3a의 4-(2,4,5-트리플루오로페닐)-3-히드록시부탄니트릴을 제조하는 단계, 및 상기 제조된 4-(2,4,5-트리플루오로페닐)-3-히드록시부탄니트릴을 강염기 존재 하에 가수분해시켜 상기 화학식 1a의 3-히드록시-4-(2,4,5-트리플루오로페닐)-부티르산을 제조하는 단계를 포함한다. That is, in the preparation method according to the present invention, 4- (2,4, Preparing 5-trifluorophenyl) -3-hydroxybutanenitrile, and hydrolyzing 4- (2,4,5-trifluorophenyl) -3-hydroxybutannitrile prepared in the presence of a strong base To prepare 3-hydroxy-4- (2,4,5-trifluorophenyl) -butyric acid of Chemical Formula 1a.

바람직하게는 하기 화학식 2b의 (2S)-2-(2,4,5-트리플루오로벤질)-옥실레인을 촉매 존재 하에서 니트릴화 반응시켜 하기 화학식 3b의 (3S)-4-(2,4,5-트리플루오로페닐)-3-히드록시부탄니트릴을 제조하는 단계(단계 1), 및 상기 제조된 (3S)-4-(2,4,5-트리플루오로페닐)-3-히드록시부탄니트릴을 강염기 존재 하에 가수분해시켜 하기 화학식 1b의 (3S)-3-히드록시-4-(2,4,5-트리플루오로페닐)-부티르산을 제조하는 단계(단계 2)를 포함한다:Preferably, (2S) -2- (2,4,5-trifluorobenzyl) -oxysilane of formula (2b) is subjected to nitrilation in the presence of a catalyst to (3S) -4- (2,4 of formula (3b). Preparation of, 5-trifluorophenyl) -3-hydroxybutanenitrile (step 1), and (3S) -4- (2,4,5-trifluorophenyl) -3-hydrate prepared above Hydrolysis of oxybutannitrile in the presence of a strong base to prepare (3S) -3-hydroxy-4- (2,4,5-trifluorophenyl) -butyric acid of formula 1b (step 2) :

Figure 112009060635890-pat00009
Figure 112009060635890-pat00009

<화학식 2b>(2b)

Figure 112009060635890-pat00010
Figure 112009060635890-pat00010

Figure 112009060635890-pat00011
Figure 112009060635890-pat00011

하기 반응식 5는 일례로 키랄 옥실레인 중 (2S)-2-(2,4,5-트리플루오로벤질)-옥실레인에 대하여 니트릴화 반응 및 가수분해를 순차적으로 진행하여 (3S)-3-히드록시-4-(2,4,5-트리플루오로페닐)-부티르산을 제조하는 방법을 나타낸 것이다. 이하 하기 반응식 5를 참조하여 각 단계별로 보다 상세히 설명한다.Scheme 5 below, for example, sequentially proceeds with nitrilation and hydrolysis of (2S) -2- (2,4,5-trifluorobenzyl) -oxysilane in chiral oxysilane (3S) -3- A method of preparing hydroxy-4- (2,4,5-trifluorophenyl) -butyric acid is shown. Hereinafter, each step will be described in more detail with reference to Scheme 5 below.

Figure 112009060635890-pat00012
Figure 112009060635890-pat00012

(단계 1)(Step 1)

상기 단계 1은 상기 화학식 2b의 (2S)-2-(2,4,5-트리플루오로벤질)-옥실레인을 촉매 존재 하에서 니트릴화 반응시켜 상기 화학식 3b의 (3S)-4-(2,4,5-트리플루오로페닐)-3-히드록시부탄니트릴을 제조하는 단계로, 구체적으로는 상기 화학식 2b의 (2S)-2-(2,4,5-트리플루오로벤질)-옥실레인을 용매에 용해시킨 후, 촉매 존재 하에서 시안화나트륨을 첨가하여 니트릴화 반응시킴으로써 화학식 3b의 (3S)-4-(2,4,5-트리플루오로페닐)-3-히드록시부탄니트릴을 제조할 수 있다.Step 1 is carried out by nitriding the (2S) -2- (2,4,5-trifluorobenzyl) -oxysilane of formula (2b) in the presence of a catalyst (3S) -4- (2, To prepare 4,5-trifluorophenyl) -3-hydroxybutanenitrile, specifically, (2S) -2- (2,4,5-trifluorobenzyl) -oxysilane of Chemical Formula 2b. (3S) -4- (2,4,5-trifluorophenyl) -3-hydroxybutanenitrile of formula 3b by dissolving in a solvent and then nitriding by adding sodium cyanide in the presence of a catalyst. Can be.

상기 (2S)-2-(2,4,5-트리플루오로벤질)-옥실레인은 신규한 화합물로서, 하기 반응식 6에 나타난 바와 같이, 2,4,5-트리플루오로벤젠 할라이드를 출발물질로 하여 (S)-에피할로히드린을 이용하는 경로 1과 알릴할라이드를 이용하는 경로 2의 방법에 의해 제조될 수 있다.The (2S) -2- (2,4,5-trifluorobenzyl) -oxysilane is a novel compound, starting from 2,4,5-trifluorobenzene halide as shown in Scheme 6 below. It can be prepared by the method of route 1 using (S)-epihalohydrin and route 2 using allyl halide.

Figure 112009060635890-pat00013
Figure 112009060635890-pat00013

경로 1Route 1

경로 1에 따른 (2S)-2-(2,4,5-트리플루오로벤질)-옥실레인의 제조방법은, 2,4,5-트리플루오로벤젠 할라이드로부터 그리그나드 시약을 제조하는 단계, 상기 제조된 그리그나드 시약을 할로겐화 구리(copper halide) 촉매 존재 하에서 (S)-에피할로히드린과 아릴화 반응(arylation)시켜 (2S)-3-(2,4,5-트리플루오로페닐)-1-할로-2-프로판올을 제조하는 단계, 및 상기 제조된 (2S)-3-(2,4,5-트리플루오로페닐)-1-할로-2-프로판올을 강염기 존재 하에 에폭시화 반응(epoxidation)시키는 단계를 포함한다. Method for preparing (2S) -2- (2,4,5-trifluorobenzyl) -oxysilane according to route 1, comprising preparing Grignard reagent from 2,4,5-trifluorobenzene halide In addition, the Grignard reagent prepared above was subjected to arylation with (S) -epihalohydrin in the presence of a copper halide catalyst (2S) -3- (2,4,5-trifluoro Preparing phenyl) -1-halo-2-propanol, and (2S) -3- (2,4,5-trifluorophenyl) -1-halo-2-propanol prepared in the presence of a strong base Epoxidation.

상세하게는, 먼저 상기 2,4,5-트리플루오로벤젠 할라이드를, 마그네슘(Mg)과 1,2-디브로모에탄 등의 유기할로겐화 알킬 또는 마그네슘과 I2를 사용하거나, 또는 이소프로필마그네슘클로라이드(i-PrMgCl)를 사용하여 그리그나드 시약(grignard reagent)으로 제조한다.Specifically, first, the 2,4,5-trifluorobenzene halide is used an organic halogenated alkyl such as magnesium (Mg) and 1,2-dibromoethane or magnesium and I 2 , or isopropyl magnesium Prepared with Grignard reagent using chloride ( i- PrMgCl).

이때 상기 2,4,5-트리플루오로벤젠 할라이드로는 2,4,5-트리플루오로벤젠 브로마이드, 2,4,5-트리플루오로벤젠 클로라이드 등을 사용할 수 있다. In this case, as the 2,4,5-trifluorobenzene halide, 2,4,5-trifluorobenzene bromide, 2,4,5-trifluorobenzene chloride, or the like may be used.

이어서 제조된 그리그나드 시약에 촉매량의 할로겐화 구리를 적가하고, (S)-에피할로히드린을 낮은 온도에서 천천히 적가하여 아릴화 반응시킴으로써 (2S)-3-(2,4,5-트리플루오로페닐)-1-할로-2-프로판올을 제조한다.Subsequently, a catalytic amount of copper halide was added dropwise to the prepared Grignard reagent, and (2S) -3- (2,4,5-tri was reacted by slowly dropping (S) -epihalohydrin at a low temperature. Prepare fluorophenyl) -1-halo-2-propanol.

상기 할로겐화 구리로는 CuBr, CuI 또는 이들의 혼합물을 사용할 수 있으며, 보다 바람직하게는 CuI를 사용할 수 있다. As the copper halide, CuBr, CuI or a mixture thereof may be used, and more preferably CuI may be used.

상기 (S)-에피할로히드린과 같은 옥실레인은 (S) 또는 (R) 이성체를 포함하며, 이들 각각의 이성체는 상업적으로 용이하게 입수할 수 있다. 구체적으로 상기 (S)-에피할로히드린으로는 (S)-에피클로로히드린을 사용할 수 있다.Oxylanes such as (S) -epihalohydrin include the (S) or (R) isomers, each of which is readily available commercially. Specifically, (S) -epichlorohydrin may be used as the (S) -epihalohydrin.

이어서 제조한 (2S)-3-(2,4,5-트리플루오로페닐)-1-할로-2-프로판올을 용매에 용해시킨 후 강염기를 첨가하여 에폭시화 반응을 실시함으로써 (2S)-2-(2,4,5-트리플루오로벤질)-옥실레인을 제조한다.Subsequently, the prepared (2S) -3- (2,4,5-trifluorophenyl) -1-halo-2-propanol was dissolved in a solvent, followed by addition of a strong base to carry out epoxidation reaction (2S) -2. Prepare-(2,4,5-trifluorobenzyl) -oxysilane.

상기 용매로는 테트라히드로퓨란, 디에틸에테르 등을 사용할 수 있다.Tetrahydrofuran, diethyl ether and the like can be used as the solvent.

또한 상기 강염기로는 수산화나트륨, 수산화칼륨, 수산화리튬 등의 알칼리 금속의 수산화물을 사용할 수 있으며, 보다 바람직하게는 수산화나트륨이다. As the strong base, hydroxides of alkali metals such as sodium hydroxide, potassium hydroxide and lithium hydroxide can be used, and more preferably sodium hydroxide.

경로 2Route 2

경로 2에 따른 (2S)-2-(2,4,5-트리플루오로벤질)-옥실레인의 제조방법은, 2,4,5-트리플루오로벤젠 할라이드로부터 그리그나드 시약을 제조하는 단계, 상기 제조된 그리그나드 시약을 알릴할라이드와 아릴화 반응시켜 3-(2,4,5-트리플루오로페닐)-1-프로펜을 제조하는 단계, 상기 제조된 3-(2,4,5-트리플루오로페닐)-1-프로펜을 산화제를 이용하여 에폭시화 반응시켜 라세믹 2-(2,4,5-트리플루오로벤질)-옥실레인을 제조하는 단계, 및 (S,S)-Co-살렌(salen)을 이용하여 상기 제조된 라세믹 2-(2,4,5-트리플루오로벤질)-옥실레인을 선택적으로 동력학적 가수분해 반응(hydrolytic kinetic resolution: HKR)시켜 (2S)-2-(2,4,5-트리플루오로벤질)-옥실레인을 제조하는 단계를 포함한다.A process for preparing (2S) -2- (2,4,5-trifluorobenzyl) -oxysilane according to route 2 includes the steps of preparing a Grignard reagent from a 2,4,5-trifluorobenzene halide. Preparing a 3- (2,4,5-trifluorophenyl) -1-propene by arylating the prepared Grignard reagent with allyl halide, and preparing the prepared 3- (2,4, Epoxidation of 5-trifluorophenyl) -1-propene with an oxidizing agent to produce racemic 2- (2,4,5-trifluorobenzyl) -oxysilane, and (S, S The hydrodynamic kinetic resolution (HKR) of the racemic 2- (2,4,5-trifluorobenzyl) -oxysilane prepared above using) -Co-salen ( Preparing 2S) -2- (2,4,5-trifluorobenzyl) -oxysilane.

상세하게는, 먼저, 상기 2,4,5-트리플루오로벤젠 할라이드로부터 그리그나드 시약을 제조한다.Specifically, first, a Grignard reagent is prepared from the 2,4,5-trifluorobenzene halide.

상기 2,4,5-트리플루오로벤젠 할라이드 및 이로부터 그리그나드 시약의 제조방법은 앞서 설명한 바와 동일하다.The 2,4,5-trifluorobenzene halide and the method for preparing Grignard reagent therefrom are the same as described above.

이어서, 제조된 그리그나드 시약에 알릴할라이드를 낮은 온도에서 천천히 적가하여 아릴화 반응시켜 3-(2,4,5-트리플루오로페닐)-1-프로펜을 제조한다.Subsequently, allylhalide is slowly added dropwise to the prepared Grignard reagent at a low temperature to be arylated to prepare 3- (2,4,5-trifluorophenyl) -1-propene.

상기 알릴할라이드로는 알릴브로마이드 등을 사용할 수 있다.As the allyl halide, allyl bromide may be used.

이어서, 수득된 3-(2,4,5-트리플루오로페닐)-1-프로펜을 용매에 용해시킨 후 산화제를 첨가하여 에폭시화 반응을 실시함으로써 라세믹 2-(2,4,5-트리플루오로벤질)-옥실레인을 제조한다.Subsequently, the obtained 3- (2,4,5-trifluorophenyl) -1-propene is dissolved in a solvent and then an oxidizing agent is added to carry out the epoxidation reaction to thereby racemic 2- (2,4,5- Prepare trifluorobenzyl) -oxysilane.

이때 상기 용매로는 테트라히드로퓨란, 디에틸에테르 등을 사용할 수 있다. In this case, tetrahydrofuran, diethyl ether, or the like may be used as the solvent.

또한 상기 산화제로는 m-ClC6H4CO3H, CH3CO3H, CF3CO3H, H2O2, 또는 이들의 혼합물 등을 사용할 수 있으며, 보다 바람직하게는 m-ClC6H4CO3H이다.In addition, the oxidizing agent may be used m- ClC 6 H 4 CO 3 H, CH 3 CO 3 H, CF 3 CO 3 H, H 2 O 2 , or a mixture thereof, more preferably m -ClC 6 H 4 CO 3 H.

이어서, 하기 화학식 4의 (S,S)-Co-살렌을 이용하여 라세믹 2-(2,4,5-트리플루오로벤질)-옥실레인을 선택적으로 HKR 시킴으로써 (2S)-2-(2,4,5-트리플루오로벤질)-옥실레인을 제조한다:Then, (2S) -2- (2 by selectively HKR racemic 2- (2,4,5-trifluorobenzyl) -oxysilane using (S, S) -Co-salen of formula (4) Prepare 4,5-trifluorobenzyl) -oxysilane:

Figure 112009060635890-pat00014
Figure 112009060635890-pat00014

상기 말단의 옥실레인을 선택적으로 HKR 시킴으로써 원하는 키랄 옥실레인을 얻는 방법은 문헌(Tetrahedron Asymmetry, 2003, 14, 1407-1446, 및 J. Am . Chem . Soc., 2002, 124, 1307-1315 참조)에 기재되어 있다. A method for obtaining the desired chiral oxysilane by selectively HKR the terminal oxysilane is described in Tetrahedron. Asymmetry , 2003, 14 , 1407-1446, and J. Am . Chem . Soc. , 2002, 124 , 1307-1315).

상기와 같은 방법으로 제조된 (2S)-2-(2,4,5-트리플루오로벤질)-옥실레인에 대한 니트릴화 반응은 디메틸포름아미드(DMF), 디메틸셀폭사이드(DMSO), 또는 탄소수 1 내지 6의 알코올(예컨대, 메탄올, 에탄올, 이소프로판올 등) 등의 용매 중에서 실시되며, 보다 바람직하게는 디메틸포름아미드이다.The nitrile reaction for (2S) -2- (2,4,5-trifluorobenzyl) -oxysilane prepared by the above method is dimethylformamide (DMF), dimethyl cellulose oxide (DMSO), or carbon number. It is implemented in solvent, such as alcohol of 1-6 (for example, methanol, ethanol, isopropanol, etc.), More preferably, it is dimethylformamide.

니트릴화 반응시 사용되는 촉매로는 NH4Cl, 구연산, 초산, 개미산, 말레산, 또는 이들의 혼합물 등을 사용할 수 있으며, 보다 바람직하게는 NH4Cl이다.As the catalyst used in the nitriding reaction, NH 4 Cl, citric acid, acetic acid, formic acid, maleic acid, or a mixture thereof may be used, and more preferably NH 4 Cl.

(단계 2)(Step 2)

단계 2는 상기 단계 1에서 제조된 (3S)-4-(2,4,5-트리플루오로페닐)-3-히드록시부탄니트릴을 강염기 존재 하에 가수분해시켜 3-히드록시-4-(2,4,5-트리플루오로페닐)-부티르산, 바람직하게는 (3S)-3-히드록시-4-(2,4,5-트리플루오로페닐)-부티르산을 제조하는 단계로, 구체적으로는 (3S)-4-(2,4,5-트리플루오로페닐)-3-히드록시부탄니트릴을 강염기 및 과산화수소의 존재 하에 가수분해시킴으로써 (3S)-3-히드록시-4-(2,4,5-트리플루오로페닐)-부티르산을 제조한다. Step 2 is hydrolysis of (3S) -4- (2,4,5-trifluorophenyl) -3-hydroxybutannitrile prepared in Step 1 in the presence of a strong base to form 3-hydroxy-4- (2 Preparing 4,5-trifluorophenyl) -butyric acid, preferably (3S) -3-hydroxy-4- (2,4,5-trifluorophenyl) -butyric acid, specifically (3S) -3-hydroxy-4- (2,4 by hydrolysis of (3S) -4- (2,4,5-trifluorophenyl) -3-hydroxybutannitrile in the presence of a strong base and hydrogen peroxide Prepare, 5-trifluorophenyl) -butyric acid.

상기 강염기로는 수산화나트륨(NaOH), 수산화칼륨(KOH), 수산화리튬(LiOH) 등의 알칼리 금속의 수산화물을 사용할 수 있고, 보다 바람직하게는 수산화나트륨이다. 상기 강염기는 수용액으로 하여 사용하는 것이 바람직하다.As the strong base, hydroxides of alkali metals such as sodium hydroxide (NaOH), potassium hydroxide (KOH) and lithium hydroxide (LiOH) can be used, and more preferably sodium hydroxide. It is preferable to use the said strong base as aqueous solution.

상기와 같은 제조방법에 의해, 시타글립틴의 주요 중간체인 3-히드록시-4-(2,4,5-트리플루오로페닐)-부티르산, 바람직하게는 (3S)-3-히드록시-4-(2,4,5-트리플루오로페닐)-부티르산을 간단하고 경제적인 방법으로 수율좋게 제조할 수 있다.By the above preparation method, 3-hydroxy-4- (2,4,5-trifluorophenyl) -butyric acid, which is the main intermediate of cytagliptin, preferably (3S) -3-hydroxy-4 -(2,4,5-trifluorophenyl) -butyric acid can be produced in good yield in a simple and economic manner.

또한 본 발명에 따른 제조방법에 있어서, (3S)-3-히드록시-4-(2,4,5-트리플루오로페닐)-부티르산 제조시의 중간체인 (2S)-2-(2,4,5-트리플루오로벤질)-옥실레인과 4-(2,4,5-트리플루오로페닐)-3-히드록시부탄니트릴은 그 자체로 신규한 화합물이다. 이에 따라 본 발명은 상기 (2S)-2-(2,4,5-트리플루오로벤질)-옥실레인 및 4-(2,4,5-트리플루오로페닐)-3-히드록시부탄니트릴을 제공한다.Furthermore, in the production method according to the present invention, (2S) -2- (2,4) which is an intermediate in the preparation of (3S) -3-hydroxy-4- (2,4,5-trifluorophenyl) -butyric acid , 5-trifluorobenzyl) -oxysilane and 4- (2,4,5-trifluorophenyl) -3-hydroxybutannitrile are themselves novel compounds. Accordingly, the present invention provides the above (2S) -2- (2,4,5-trifluorobenzyl) -oxysilane and 4- (2,4,5-trifluorophenyl) -3-hydroxybutannitrile. to provide.

이하, 하기 제조예 및 실시예에 의하여 본 발명을 더욱 상세하게 설명하고자 한다. 단, 하기 제조예 및 실시예는 본 발명을 예시하기 위한 것일 뿐 본 발명의 범위가 이들만으로 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail by the following Preparation Examples and Examples. However, the following Preparation Examples and Examples are only for illustrating the present invention, and the scope of the present invention is not limited thereto.

제조예Manufacturing example 1: (2S)-2-(2,4,5- 1: (2S) -2- (2,4,5- 트리플루오로벤질Trifluorobenzyl )-) - 옥실레인의Oxirane 제조 Produce

Figure 112009060635890-pat00015
Figure 112009060635890-pat00015

단계 1: (2S)-3-(2,4,5-트리플루오로페닐)-1-클로로-2-프로판올의 제조Step 1: Preparation of (2S) -3- (2,4,5-trifluorophenyl) -1-chloro-2-propanol

마그네슘(Mg)(1.26 g)을 테트라히드로퓨란(THF) 용매 10 ml에 넣고, 1,2-디브로모에탄 한방울을 적가한 후, 2,4,5-트리플루오로벤젠 브로마이드(0.55 g)를 천천히 적가하고, 30분 동안 교반하였다. 결과의 반응혼합물에, THF 50 ml에 용해시킨 2,4,5-트리플루오로벤젠 브로마이드(9.0 g) 용액을 30분 동안에 걸쳐 천천히 더 적가하였다. 결과의 반응혼합물을 상온에서 1시간 교반한 후, CuI(0.72 g)을 첨가하고, 반응온도를 0 ℃로 내렸다. 냉각시킨 반응혼합물에, THF 용매 40 ml에 희석시킨 (S)-에피클로로히드린(4.1 ml)을 30분 동안에 걸쳐 천천히 적가하고, 상온으로 승온시켜 2시간 동안 교반하였다. 결과로 수득된 반응혼합물에 포화 NH4Cl 50 ml와 에틸아세테이트 50 ml를 첨가하고, 유기층을 분리하였다. 분리된 유기층을 포화 소금물 50 ml로 세척하고, MgSO4로 건조한 후 MgSO4을 여과하여 제거하고, 잔부 중의 유기용매를 감압 하에서 제거함으로써, 표제 화합물을 수득하였다.Magnesium (Mg) (1.26 g) was added to 10 ml of tetrahydrofuran (THF) solvent, and a drop of 1,2-dibromoethane was added dropwise, followed by 2,4,5-trifluorobenzene bromide (0.55 g). Was slowly added dropwise and stirred for 30 minutes. To the resulting reaction mixture was slowly added dropwise a solution of 2,4,5-trifluorobenzene bromide (9.0 g) dissolved in 50 ml of THF over 30 minutes. After stirring the resulting reaction mixture at room temperature for 1 hour, CuI (0.72 g) was added and the reaction temperature was lowered to 0 deg. To the cooled reaction mixture, (S) -epichlorohydrin (4.1 ml) diluted in 40 ml of THF solvent was slowly added dropwise over 30 minutes, warmed to room temperature and stirred for 2 hours. 50 ml of saturated NH 4 Cl and 50 ml of ethyl acetate were added to the resulting reaction mixture, and the organic layer was separated. By washing the separated organic layer with saturated brine 50 ml, dried with MgSO 4 filtered off the MgSO 4, remove the organic solvent in the remainder under reduced pressure to give the title compound.

단계 2: (2S)-2-(2,4,5-트리플루오로벤질)-옥실레인의 제조Step 2: Preparation of (2S) -2- (2,4,5-trifluorobenzyl) -oxysilane

상기 단계 1에서 제조한 (2S)-3-(2,4,5-트리플루오로페닐)-1-클로로-2-프로판올을 메탄올 50 ml에 용해시킨 후 NaOH(2.3 g)을 적가하여 반응혼합물을 제조하였다. 수득된 반응혼합물을 1시간 동안 교반한 후, 감압 하에서 메탄올을 제거하고, 물 50 ml와 에틸아세테이트 50 ml를 첨가하고, 유기층을 분리하였다. 분리된 유기층을 포화소금물로 세척하고, MgSO4로 건조한 후, MgSO4를 여과하여 제거하고, 잔부 중의 유기용매를 감압 하에서 제거함으로써 표제 화합물(6.8 g, 수율: 80 %)을 수득하였다.After dissolving (2S) -3- (2,4,5-trifluorophenyl) -1-chloro-2-propanol prepared in step 1 in 50 ml of methanol, the reaction mixture was added dropwise with NaOH (2.3 g). Was prepared. After stirring the obtained reaction mixture for 1 hour, methanol was removed under reduced pressure, 50 ml of water and 50 ml of ethyl acetate were added, and the organic layer was separated. The separated organic layer washed with saturated brine and dried with MgSO 4, the title compound (6.8 g, yield: 80%) was filtered to remove MgSO 4, remove the organic solvent in the remainder under reduced pressure to give the.

1H-NMR(300MHz, CDCl3) : δ 7.17-7.05 (2H, m), 6.96-6.88 (2H, m), 3.16-3.13 (1H, m) 3.14 (1H, dd, J=4.68, 14.7), 2.82-2.77 (2H, m), 2.54-2.47 (1H, m). 1 H-NMR (300 MHz, CDCl 3 ): δ 7.17-7.05 (2H, m), 6.96-6.88 (2H, m), 3.16-3.13 (1H, m) 3.14 (1H, dd, J = 4.68, 14.7) , 2.82-2.77 (2H, m), 2.54-2.47 (1H, m).

제조예Manufacturing example 2: (2S)-2-(2,4,5- 2: (2S) -2- (2,4,5- 트리플루오로벤질Trifluorobenzyl )-) - 옥실레인의Oxysilane 제조 Produce

Figure 112009060635890-pat00016
Figure 112009060635890-pat00016

단계 1: (2S)-3-(2,4,5-트리플루오로페닐)-1-클로로-2-프로판올의 제조Step 1: Preparation of (2S) -3- (2,4,5-trifluorophenyl) -1-chloro-2-propanol

2,4,5-트리플루오로벤젠 브로마이드(9.55 g)를 THF 30 ml에 용해시킨 용액에 2N i-PrMgCl(THF 중) 26 ml를 반응온도 -15 ℃에서 60분 동안에 걸쳐 천천히 적가하고, 이어서 -15 ℃에서 CuI(0.72 g)을 첨가하여 반응혼합물을 제조한 후 -10 ℃로 반응온도를 올렸다. 상기 반응혼합물에 THF 용매 40 ml 중에 희석시킨 (S)-에피클로로히드린(4.1 ml)을 30분 동안에 걸쳐 천천히 적가하고, 0 ℃에서 1시간 동안 교반하였다. 결과의 반응 혼합물에 포화 NH4Cl 50ml와 에틸아세테이트 50ml를 첨가하고, 유기층을 분리하였다. 분리된 유기층을 포화 소금물 50 ml로 세척하고, MgSO4로 건조한 후 MgSO4을 여과로 제거하고, 잔부 중의 유기용매를 감압 하에서 제거함으로써 표제 화합물을 수득하였다.To a solution of 2,4,5-trifluorobenzene bromide (9.55 g) dissolved in 30 ml of THF, 26 ml of 2N i -PrMgCl (in THF) was slowly added dropwise over 60 minutes at a reaction temperature of -15 ° C. CuI (0.72 g) was added at -15 ° C to prepare a reaction mixture, and the reaction temperature was raised to -10 ° C. To the reaction mixture was slowly added dropwise (S) -epichlorohydrin (4.1 ml) diluted in 40 ml of THF solvent over 30 minutes and stirred at 0 ° C. for 1 hour. 50 ml of saturated NH 4 Cl and 50 ml of ethyl acetate were added to the resulting reaction mixture, and the organic layer was separated. By washing the separated organic layer with saturated brine 50 ml, dried with MgSO 4 to remove the MgSO 4 by filtration, remove the organic solvent in the remainder under reduced pressure to give the title compound.

단계 2: (2S)-2-(2,4,5-트리플루오로벤질)-옥실레인의 제조Step 2: Preparation of (2S) -2- (2,4,5-trifluorobenzyl) -oxysilane

상기 단계 1에서 수득한 (2S)-3-(2,4,5-트리플루오로페닐)-1-클로로-2-프로판올을 메탄올 50 ml에 용해시킨 후 NaOH(2.3 g)을 적가하여 반응혼합물을 제조하였다. 수득된 반응혼합물을 1시간 동안 교반한 후, 감압 하에서 메탄올을 제거하 고, 물 50 ml와 에틸아세테이트 50 ml를 첨가하고, 유기층을 분리하였다. 분리된 유기층을 포화소금물로 세척하고, MgSO4로 건조한 후, MgSO4를 여과하여 제거하고, 잔부 중의 유기용매를 감압 하에서 제거함으로써 표제 화합물(7.6 g, 수율: 85 %)을 얻었다.After dissolving (2S) -3- (2,4,5-trifluorophenyl) -1-chloro-2-propanol obtained in step 1 in 50 ml of methanol, NaOH (2.3 g) was added dropwise to the reaction mixture. Was prepared. After stirring the obtained reaction mixture for 1 hour, methanol was removed under reduced pressure, 50 ml of water and 50 ml of ethyl acetate were added, and the organic layer was separated. The separated organic layer washed with saturated brine, dried with MgSO 4, filtered to remove MgSO 4, and by removing the organic solvent in the remainder under reduced pressure to give the title compound (7.6 g, yield: 85%) was obtained.

제조예Manufacturing example 3: 2-(2,4,5- 3: 2- (2,4,5- 트리플루오로벤질Trifluorobenzyl )-) - 옥실레인의Oxirane 제조 Produce

Figure 112009060635890-pat00017
Figure 112009060635890-pat00017

단계 1: 아릴화반응에 의한 3-(2,4,5-트리플루오로페닐)-1-프로펜의 제조 Step 1: Preparation of 3- (2,4,5-trifluorophenyl) -1-propene by arylation reaction

Mg(3.9 g)을 THF 용매 30 ml에 넣고, 1,2-디브로모에탄 0.2 g을 적가한 후 2,4,5-트리플루오로벤젠 브로마이드(3.6 g)를 천천히 적가하고, 30분 동안 교반하였다. 상기 반응혼합물에 THF 60 ml에 용해시킨 2,4,5-트리플루오로벤젠 브로마이드(25 g) 용액을 60분 동안에 걸쳐 천천히 더 적가하였다. 결과의 반응혼합물을 상온에서 1시간 교반한 후, 반응온도를 -10 ℃로 내렸다. 냉각된 반응혼합물에, THF 용매 60 ml에 희석시킨 알릴 브로마이드(18.0 g)를 20분 동안에 걸쳐 천천히 적가한 후 1시간 동안 교반하고, 상온으로 온도를 올려 다시 1시간 동안 교반하였다. 결과로 수득된 반응혼합물에 디클로로메탄(MC) 300 ml를 적가하여 유기층을 분리하였다. 분리된 유기층을 2 M NH4Cl 150 ml로 세척하고, 연속하여 물 150 ml로 세척 한 후, MgSO4로 건조하였다. MgSO4를 여과하여 제거하고, 잔부 중의 유기용매를 감압 하에서 제거함으로써 표제 화합물을 수득하였다.Mg (3.9 g) was added to 30 ml of THF solvent, 0.2 g of 1,2-dibromoethane was added dropwise, followed by slowly dropping 2,4,5-trifluorobenzene bromide (3.6 g) for 30 minutes. Stirred. To the reaction mixture was slowly added dropwise a solution of 2,4,5-trifluorobenzene bromide (25 g) dissolved in 60 ml of THF over 60 minutes. The resulting reaction mixture was stirred at room temperature for 1 hour, and then the reaction temperature was lowered to -10 ° C. To the cooled reaction mixture, allyl bromide (18.0 g) diluted in 60 ml of THF solvent was slowly added dropwise over 20 minutes, followed by stirring for 1 hour, and the temperature was raised to room temperature, followed by stirring for 1 hour. 300 ml of dichloromethane (MC) was added dropwise to the resulting reaction mixture to separate the organic layer. The separated organic layer was washed with 150 ml of 2 M NH 4 Cl, washed successively with 150 ml of water, and then dried over MgSO 4 . MgSO 4 was filtered off and the organic solvent in the residue was removed under reduced pressure to afford the title compound.

단계 2: 에폭시화 반응에 의한 2-(2,4,5-트리플루오로벤질)-옥실레인의 제조Step 2: Preparation of 2- (2,4,5-trifluorobenzyl) -oxysilane by epoxidation reaction

단계 1에서 수득한 3-(2,4,5-트리플루오로페닐)-1-프로펜을 300 ml 디클로로메탄에 용해시킨 후 m-CPBA(35 g)을 천천히 적가하여 제조한 반응혼합물을 17시간 동안 교반하였다. 상기 반응혼합물에 포화 NaHCO3 300 ml를 천천히 적가하고, 유기층을 분리하였다. 분리된 유기층을 1 N NaOH 300 ml로 세척하고, 이어서 브라인 100 ml로 세척한 후, MgSO4로 건조하고, MgSO4를 여과하여 제거하였다. 잔부 중의 유기용매를 감압 하에서 제거함으로써 표제 화합물(19.1 g, 수율: 75%)을 수득하였다.The reaction mixture was prepared by dissolving 3- (2,4,5-trifluorophenyl) -1-propene obtained in step 1 in 300 ml dichloromethane and slowly dropwise adding m-CPBA (35 g). Stir for hours. 300 ml of saturated NaHCO 3 was slowly added dropwise to the reaction mixture, and the organic layer was separated. The separated organic layer washed with 1 N NaOH 300 ml, and then was removed by and washed with brine 100 ml, dried over MgSO 4, filtered and the MgSO 4. The organic solvent in the residue was removed under reduced pressure to give the title compound (19.1 g, yield: 75%).

제조예Manufacturing example 4: (2S)-2-(2,4,5- 4: (2S) -2- (2,4,5- 트리플루오로벤질Trifluorobenzyl )-) - 옥실레인의Oxirane 제조 Produce

Figure 112009060635890-pat00018
Figure 112009060635890-pat00018

상온에서 반응기에 (S,S)-Co-살렌(302 mg), 2-(2,4,5-트리플루오로벤질)-옥실레인(18.8g), AcOH(120 μL)와 THF(1 mL)를 넣고 혼합하여 반응혼합물을 제조하 였다. 제조된 반응혼합물의 반응온도를 0 ℃로 낮춘 후, H2O(1.0 ml)를 한번에 적가하고, 상온에서 24시간 교반한 후, 감압 하에서 THF를 제거하였다. 잔사를 컬럼분리하여 표제화합물(7.71 g, 수율: 41 %)을 수득하였다.(S, S) -Co-salen (302 mg), 2- (2,4,5-trifluorobenzyl) -oxysilane (18.8 g), AcOH (120 μL) and THF (1 mL) at room temperature ) Was added and mixed to prepare a reaction mixture. After the reaction temperature of the prepared reaction mixture was lowered to 0 ° C., H 2 O (1.0 ml) was added dropwise at once, stirred at room temperature for 24 hours, and then THF was removed under reduced pressure. The residue was separated by column to give the title compound (7.71 g, yield: 41%).

제조예Manufacturing example 5 : (3S)-4-(2,4,5- 5: (3S) -4- (2,4,5- 트리플루오로페닐Trifluorophenyl )-3-) -3- 히드록시부탄니트릴의Of hydroxybutanenitrile 제조 Produce

Figure 112009060635890-pat00019
Figure 112009060635890-pat00019

(2S)-2-(2,4,5-트리플루오로벤질)-옥실레인(5.30 g)을 MeOH 25 mL에 용해시킨 용액에, 물 10 mL에 용해시킨 NaCN(2.07 g)과 NH4Cl (1.96 g)을 차례로 첨가한 후 온도를 50 ℃로 승온시켰다. 3 시간 교반 후, 반응혼합물중의 용매를 감압 증류 하에서 제거하고, 물 25 ml와 에틸아세테이트 25 mL를 넣어 유기층을 분리하였다. 분리된 유기층을 포화소금물 25 mL로 2회 세척하고, MgSO4로 건조한 후, MgSO4를 여과하여 제거하고, 잔부 중의 유기용매를 감압 하에서 제거하였다. 얻어진 잔사를 컬럼분리하여 표제 화합물(5.59 g, 수율: 92%)을 수득하였다.(2S) -2- (2,4,5-trifluorobenzyl) -oxysilane (5.30 g) in a solution of 25 mL of MeOH, NaCN (2.07 g) and NH 4 Cl dissolved in 10 mL of water (1.96 g) was added sequentially and the temperature was raised to 50 ° C. After stirring for 3 hours, the solvent in the reaction mixture was removed under reduced pressure distillation, 25 ml of water and 25 ml of ethyl acetate were added to separate an organic layer. Washed twice with saturated brine. The separated organic layer was 25 mL, which was then dried with MgSO 4, filtered to remove MgSO 4, remove the organic solvent in the remainder under reduced pressure. The obtained residue was separated by column to give the title compound (5.59 g, yield: 92%).

1H-NMR(300MHz, CDCl3) : δ 7.19-7.08 (2H, m), 6.99-6.90 (2H, m), 4.24-4.15 (1H, m), 2.96-2.83 (2H, m), 2.65-2.48 (2H, m) 1 H-NMR (300 MHz, CDCl 3 ): δ 7.19-7.08 (2H, m), 6.99-6.90 (2H, m), 4.24-4.15 (1H, m), 2.96-2.83 (2H, m), 2.65- 2.48 (2H, m)

실시예Example 1: (3S)-3-히드록시-4-(2,4,5- 1: (3S) -3-hydroxy-4- (2,4,5- 트리플루오로페닐Trifluorophenyl )-부티르산의 제조Preparation of Butyric Acid

Figure 112009060635890-pat00020
Figure 112009060635890-pat00020

상온에서 반응기에 상기 제조예 5에서 제조된 (3S)-4-(2,4,5-트리플루오로페닐)-3-히드록시부탄니트릴(5.59 g)을 MeOH 20 mL에 용해시킨 후, 30 % H2O2(5.31 mL)와 NaOH(2.60 g)을 차례로 첨가하여 반응혼합물을 제조하고, 내부 온도를 약 70 ℃로 승온시켰다. 상기 온도에서 반응혼합물을 6 시간 환류 교반한 후, 반응온도를 0 ℃로 낮추고 2N HCl(aq) (28.0 mL)을 서서히 첨가하였다. 결과의 반응혼합물에 에틸아세테이트 30mL를 넣어 유기층을 분리하고, 분리된 유기층을 포화소금물 30mL로 2회 세척하고, MgSO4로 건조한 후, MgSO4를 여과하여 제거하고, 잔부 중의 유기용매를 감압 하에서 제거하였다. 얻어진 잔사를 컬럼분리하여 표제화합물(5.48 g, 수율: 90 %)을 수득하였다. After dissolving (3S) -4- (2,4,5-trifluorophenyl) -3-hydroxybutannitrile (5.59 g) prepared in Preparation Example 5 in a reactor at room temperature in 30 mL of MeOH, % H 2 O 2 (5.31 mL) and NaOH (2.60 g) were added sequentially to prepare a reaction mixture, and the internal temperature was raised to about 70 ° C. After the reaction mixture was stirred at reflux for 6 hours at a temperature, the reaction temperature was lowered to 0 ° C. and 2N HCl (aq) (28.0 mL) was added slowly. To the reaction the resultant mixture into the organic layer was separated and ethyl acetate 30mL, washed twice The separated organic layer with saturated brine 30mL, dried with MgSO 4, filtered to remove MgSO 4, remove the organic solvent in the remainder under reduced pressure It was. The obtained residue was separated by column to give the title compound (5.48 g, yield: 90%).

1H-NMR(300MHz, CDCl3) : δ 7.27-7.07 (2H, m), 6.96-6.86 (2H, m), 6.0 (1H, br), 4.30-4.22 (m, 1H), 2.79 (2H, d, J=6.3), 2.61-2.44 (m, 2H) 1 H-NMR (300 MHz, CDCl 3 ): δ 7.27-7.07 (2H, m), 6.96-6.86 (2H, m), 6.0 (1H, br), 4.30-4.22 (m, 1H), 2.79 (2H, d, J = 6.3), 2.61-2.44 (m, 2H)

Claims (15)

하기 화학식 2a의 2-(2,4,5-트리플루오로벤질)-옥실레인을 NH4Cl 존재 하에서 니트릴화 반응시켜 하기 화학식 3a의 4-(2,4,5-트리플루오로페닐)-3-히드록시부탄니트릴을 제조하는 단계, 및2- (2,4,5-trifluorobenzyl) -oxysilane of formula (2a) was subjected to nitrile reaction in the presence of NH 4 Cl to form 4- (2,4,5-trifluorophenyl)- Preparing 3-hydroxybutanenitrile, and 상기 제조된 4-(2,4,5-트리플루오로페닐)-3-히드록시부탄니트릴을 강염기 존재 하에 가수분해시키는 단계를 포함하는, 하기 화학식 1a의 3-히드록시-4-(2,4,5-트리플루오로페닐)-부티르산의 제조방법: Hydrolysis of the prepared 4- (2,4,5-trifluorophenyl) -3-hydroxybutannitrile in the presence of a strong base, 3-hydroxy-4- (2, Method for preparing 4,5-trifluorophenyl) -butyric acid: <화학식 1a><Formula 1a>
Figure 112012081305600-pat00021
Figure 112012081305600-pat00021
<화학식 2a>&Lt; EMI ID =
Figure 112012081305600-pat00022
Figure 112012081305600-pat00022
<화학식 3a><Formula 3a>
Figure 112012081305600-pat00023
Figure 112012081305600-pat00023
제 1 항에 있어서, The method of claim 1, 상기 2-(2,4,5-트리플루오로벤질)-옥실레인이 하기 화학식 2b의 (2S)-2-(2,4,5-트리플루오로벤질)-옥실레인인 것을 특징으로 하는 제조방법: The 2- (2,4,5-trifluorobenzyl) -oxysilane is characterized in that (2S) -2- (2,4,5-trifluorobenzyl) -oxysilane of formula 2b Way: <화학식 2b>(2b)
Figure 112009060635890-pat00024
Figure 112009060635890-pat00024
삭제delete 제 1 항에 있어서, The method of claim 1, 상기 니트릴화 반응이 시안화나트륨을 사용하여 실시되는 것을 특징으로 하는 제조방법.Said nitrile reaction is carried out using sodium cyanide. 제 1 항에 있어서, The method of claim 1, 상기 강염기가 수산화나트륨, 수산화칼륨, 수산화리튬 및 이들의 혼합물로 이루어진 군에서 선택되는 것을 특징으로 하는 제조방법. The strong base is selected from the group consisting of sodium hydroxide, potassium hydroxide, lithium hydroxide and mixtures thereof. 제 1 항에 있어서,The method of claim 1, 상기 2-(2,4,5-트리플루오로벤질)-옥실레인이, 2- (2,4,5-trifluorobenzyl) -oxysilane, 2,4,5-트리플루오로벤젠 할라이드로부터 그리그나드 시약을 제조하는 단계, Preparing a Grignard reagent from a 2,4,5-trifluorobenzene halide, 상기 제조된 그리그나드 시약을 할로겐화 구리 촉매 존재 하에서 (S)-에피할로히드린과 아릴화반응시켜 (2S)-3-(2,4,5-트리플루오로페닐)-1-할로-2-프로판올을 제조하는 단계, 및 The Grignard reagent prepared above was arylated with (S) -epihalohydrin in the presence of a halogenated copper catalyst to give (2S) -3- (2,4,5-trifluorophenyl) -1-halo- Preparing 2-propanol, and 상기 제조된 (2S)-3-(2,4,5-트리플루오로페닐)-1-할로-2-프로판올을 강염기존재 하에 에폭시화 반응시키는 단계를 포함하는 제조방법에 의해 제조되는 것을 특징으로 하는 제조방법.(2S) -3- (2,4,5-trifluorophenyl) -1-halo-2-propanol prepared by the preparation method comprising the step of epoxidation in the presence of a strong base. Manufacturing method. 제 6 항에 있어서, The method of claim 6, 상기 2,4,5-트리플루오로벤젠 할라이드가 2,4,5-트리플루오로벤젠 브로마이드, 2,4,5-트리플루오로벤젠 클로라이드 및 이들의 혼합물로 이루어진 군에서 선택되는 것을 특징으로 하는 제조방법.The 2,4,5-trifluorobenzene halide is selected from the group consisting of 2,4,5-trifluorobenzene bromide, 2,4,5-trifluorobenzene chloride and mixtures thereof Manufacturing method. 제 6 항에 있어서, The method of claim 6, 상기 할로겐화 구리 촉매가 CuBr, CuI 및 이들의 혼합물로 이루어진 군에서 선택되는 것을 특징으로 하는 제조방법. The halogenated copper catalyst is selected from the group consisting of CuBr, CuI and mixtures thereof. 제 6 항에 있어서, The method of claim 6, 상기 강염기가 수산화나트륨, 수산화칼륨, 수산화리튬 및 이들의 혼합물로 이루어진 군에서 선택되는 것을 특징으로 하는 제조방법.The strong base is selected from the group consisting of sodium hydroxide, potassium hydroxide, lithium hydroxide and mixtures thereof. 제 1 항에 있어서,The method of claim 1, 상기 2-(2,4,5-트리플루오로벤질)-옥실레인이, 2- (2,4,5-trifluorobenzyl) -oxysilane, 2,4,5-트리플루오로벤젠 할라이드로부터 그리그나드 시약을 제조하는 단계;Preparing a Grignard reagent from a 2,4,5-trifluorobenzene halide; 상기 제조된 그리그나드 시약을 알릴할라이드와 아릴화 반응시켜 3-(2,4,5-트리플루오로페닐)-1-프로펜을 제조하는 단계; Preparing a 3- (2,4,5-trifluorophenyl) -1-propene by arylating the prepared Grignard reagent with allyl halide; 상기 제조된 3-(2,4,5-트리플루오로페닐)-1-프로펜을 산화제를 이용하여 에폭시화 반응시켜 라세믹 2-(2,4,5-트리플루오로벤질)-옥실레인을 제조하는 단계; 및 The 3- (2,4,5-trifluorophenyl) -1-propene prepared above was epoxidized using an oxidizing agent to racemic 2- (2,4,5-trifluorobenzyl) -oxysilane. Preparing a; And 상기 제조된 라세믹 2-(2,4,5-트리플루오로벤질)-옥실레인을 선택적으로 동력학적 가수분해 반응시키는 단계를 포함하는 제조방법에 의해 제조되는 것을 특징으로 하는 제조방법.A process for producing the racemic 2- (2,4,5-trifluorobenzyl) -oxysilane prepared by the preparation method comprising the step of selectively hydrolyzing. 제 10 항에 있어서, 11. The method of claim 10, 상기 2,4,5-트리플루오로벤젠 할라이드가 2,4,5-트리플루오로벤젠 브로마이드, 2,4,5-트리플루오로벤젠 클로라이드 및 이들의 혼합물로 이루어진 군에서 선택되는 것을 특징으로 하는 제조방법.The 2,4,5-trifluorobenzene halide is selected from the group consisting of 2,4,5-trifluorobenzene bromide, 2,4,5-trifluorobenzene chloride and mixtures thereof Manufacturing method. 제 10 항에 있어서, 11. The method of claim 10, 상기 산화제가 m-ClC6H4CO3H, CH3CO3H, CF3CO3H, H2O2 및 이들의 혼합물로 이루어진 군에서 선택되는 것을 특징으로 하는 제조방법.The oxidizing agent is selected from the group consisting of m- ClC 6 H 4 CO 3 H, CH 3 CO 3 H, CF 3 CO 3 H, H 2 O 2 and mixtures thereof. 제 10 항에 있어서, 11. The method of claim 10, 상기 동력학적 가수분해 반응이 하기 화학식 4의 (S,S)-Co-살렌(salen)을 사용하여 실시되는 것을 특징으로 하는 제조방법:The kinetic hydrolysis reaction is carried out using (S, S) -Co-salen of the following formula (4): <화학식 4> &Lt; Formula 4 >
Figure 112009060635890-pat00025
Figure 112009060635890-pat00025
하기 화학식 2b의 (2S)-2-(2,4,5-트리플루오로벤질)-옥실레인:(2S) -2- (2,4,5-trifluorobenzyl) -oxysilane of formula (2b) <화학식 2b>(2b)
Figure 112009060635890-pat00026
Figure 112009060635890-pat00026
하기 화학식 3a의 4-(2,4,5-트리플루오로페닐)-3-히드록시부탄니트릴:4- (2,4,5-trifluorophenyl) -3-hydroxybutanenitrile of Formula 3a: <화학식 3a><Formula 3a>
Figure 112009060635890-pat00027
Figure 112009060635890-pat00027
KR1020090093894A 2009-10-01 2009-10-01 Method for preparing intermediate of sitagliptin using chiral oxirane KR101253106B1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
KR1020090093894A KR101253106B1 (en) 2009-10-01 2009-10-01 Method for preparing intermediate of sitagliptin using chiral oxirane
PCT/KR2010/006346 WO2011040717A2 (en) 2009-10-01 2010-09-16 Method for preparing intermediate of sitagliptin using chiral oxirane
ARP100103536A AR079102A1 (en) 2009-10-01 2010-09-29 A METHOD TO PREPARE A SITAGLIPTIN INTERMEDIATE PRODUCT USING A CHIRAL OXIRANE
TW099133271A TW201118101A (en) 2009-10-01 2010-09-30 Method for preparing intermediate of sitagliptin using chiral oxirane

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020090093894A KR101253106B1 (en) 2009-10-01 2009-10-01 Method for preparing intermediate of sitagliptin using chiral oxirane

Publications (2)

Publication Number Publication Date
KR20110036308A KR20110036308A (en) 2011-04-07
KR101253106B1 true KR101253106B1 (en) 2013-04-10

Family

ID=43826758

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020090093894A KR101253106B1 (en) 2009-10-01 2009-10-01 Method for preparing intermediate of sitagliptin using chiral oxirane

Country Status (4)

Country Link
KR (1) KR101253106B1 (en)
AR (1) AR079102A1 (en)
TW (1) TW201118101A (en)
WO (1) WO2011040717A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102838511A (en) * 2011-06-24 2012-12-26 浙江海翔药业股份有限公司 Sitagliptin intermediates as well as preparation method and application of intermediate
CN113979853A (en) * 2021-11-24 2022-01-28 上海科利生物医药有限公司 Preparation method of (S) -3-hydroxy-4- (2,4, 5-trifluorophenyl) butyric acid

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090192326A1 (en) 2007-11-13 2009-07-30 Nurit Perlman Preparation of sitagliptin intermediate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2108767A2 (en) * 1970-10-02 1972-05-26 Synthelabo 2-carbamyloxy-3-phenylbutyronitriles - with hypnotic activity
WO2004087650A2 (en) * 2003-03-27 2004-10-14 Merck & Co. Inc. Process and intermediates for the preparation of beta-amino acid amide dipeptidyl peptidase-iv inhibitors
WO2009045507A2 (en) * 2007-10-03 2009-04-09 Teva Pharmaceutical Industries Ltd. Processes for preparing an intermediate of sitagliptin via enzymatic reduction

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090192326A1 (en) 2007-11-13 2009-07-30 Nurit Perlman Preparation of sitagliptin intermediate

Also Published As

Publication number Publication date
KR20110036308A (en) 2011-04-07
TW201118101A (en) 2011-06-01
WO2011040717A3 (en) 2011-10-13
AR079102A1 (en) 2011-12-28
WO2011040717A2 (en) 2011-04-07

Similar Documents

Publication Publication Date Title
KR101222679B1 (en) Method of preparing sitagliptin and intermediates used therein
CN101993406B (en) Indoline compound with optical activity and preparation method thereof
CN103819475B (en) Synthetic method of sitagliptin and salt thereof
CN101993407A (en) Indoline compound for preparing silodosin and preparation method thereof
CN102702067B (en) Novel intermediate for synthesizing silodosin as well as preparation method and purpose of novel intermediate
CN102757431B (en) A kind of novel method of synthesizing sitagliptin
CN106187808A (en) The preparation method of AHU-377, AHU-377 intermediate and the preparation method of AHU-377 intermediate
CN102627648B (en) Preparation method of sitagliptin
CN1931838A (en) Azetidinone derivative and synthetic method thereof
KR101253106B1 (en) Method for preparing intermediate of sitagliptin using chiral oxirane
WO2015035735A1 (en) Method for preparing intermediate compound of sitagliptin
HUE033534T2 (en) Asymmetric synthesis of a substituted pyrrolidine-2-carboxamide
CN109456253A (en) A kind of method of chiral induction synthesis (S) -3- (4- bromophenyl)-piperidines or its salt
CN113788777B (en) Method for preparing 1-substituted-3-carbonyl pyrrole
JP4288311B2 (en) Method for producing optically active amino alcohol
CN105111134A (en) Method for preparing (R)-or(S)-3-aminopiperidine dihydrochloride
KR101177821B1 (en) Method for preparing intermediate of sitagliptin and intermediates used therein
KR101072479B1 (en) Method for Preparing Racemic or Optically Active 3―Hydroxypyrrolidine or Derivatives Thereof
KR101491007B1 (en) Process for preparing ezetimibe intermediate
JP4855446B2 (en) Process for the production of optically pure (S) -3-hydroxypyrrolidine
JP2007284358A (en) Method for producing optically active piperazine compound
EP2684864A1 (en) Method of producing optically active 1-amino-2-vinylcyclopropane carboxylic acid ester
CN109053658A (en) A kind of new method preparing Ao Gelieting key intermediate
JP2003137835A (en) Method for producing (r)-3-hydroxy-3-(2-phenyl)hexanoic acid
KR20120045905A (en) Heterocyclic ring fused pyrido compounds and process for preparing them

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee